This is a historical report — it no longer reflects this drug's current status. Current status: Active Shortage. View this drug's full profile page →
APO-VALPROIC ACID ORAL SOLUTION
APOTEX INC
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is there a shortage of APO-VALPROIC ACID ORAL SOLUTION in Canada?
Yes. APO-VALPROIC ACID ORAL SOLUTION 250MG has an active shortage reported to Health Canada (last updated December 5, 2024).
Why is APO-VALPROIC ACID ORAL SOLUTION not available?
The reason the manufacturer reported: Disruption of the manufacture of the drug.
When will APO-VALPROIC ACID ORAL SOLUTION be available again?
No estimated resolution date has been reported yet. Follow this page to get an email as soon as the status changes.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
VALPROIC ACID ORAL SOLUTION
APOTEX INC
Other Products
MYLAN-VALPROIC
MYLAN PHARMACEUTICALS ULC
NOVO-VALPROIC
TEVA CANADA LIMITED
RATIO-VALPROIC
TEVA CANADA LIMITED
RATIO-VALPROIC-CAP 250MG
RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED
VALPROIC ACID
APOTEX INC
What this means
Does this mean I need to switch medications right away?
Not necessarily right away, but this product will not be returning to the market.
What should I do?
Talk to your pharmacist or prescriber about your options well before your current supply runs out.
DIN
02238370
Strength
250MG
Dosage Form
SOLUTION
Route
ORAL
Active Ingredient
VALPROIC ACID
Tier
Unrated
Last Updated
2023-11-02
Reason for Shortage
Business reasons
Past Reports for This Drug
APO-VALPROIC ACID ORAL SOLUTION has 2 shortage/discontinuation reports on file — this is one of them.
Other Products from APOTEX INC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
50MCG · DIN 02460513
325MG · DIN 02362341
500MG · DIN 02362368
DIN 02290901
325MG · DIN 02362422
500MG · DIN 02362244
10MG · DIN 02240414
20MG · DIN 02296098
150MG · DIN 02296160
75MG · DIN 02230507
2MG · DIN 02554194
2MG · DIN 02554178